(Q44685341)

English

A comparison of the efficacy and tolerability of tamsulosin and finasteride in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

A comparison of the efficacy and tolerability of tamsulosin and finasteride in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Roberto Mario Scarpa

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

author name string

P Rigatti

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

M Brausi

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

D Porru

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

H Schumacher

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

C A Rizzi

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

MICTUS Study Group

7

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Prostate Cancer and Prostatic Diseases

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

315-323

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500680

0 references

The development and validation of a quality-of-life measure to assess partner morbidity in benign prostatic enlargement.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500680

21 January 2018

A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500680

21 January 2018

Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia. European ALFIN Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500680

21 January 2018

Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500680

21 January 2018

Potential mechanisms of action of superselective alpha(1)-adrenoceptor antagonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500680

21 January 2018

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500680

21 January 2018

Finasteride. A review of its potential in the treatment of benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500680

21 January 2018

5 alpha-reductase inhibitors: what's new?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500680

21 January 2018

The International Continence Society “Benign Prostatic Hyperplasia” Study: The Bothersomeness of Urinary Symptoms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500680

21 January 2018

Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500680

21 January 2018

Who should be treated and how? Evidence-based medicine in symptomatic BPH

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500680

7 January 2021

based on heuristic

inferred from DOI database lookup

Introduction and Concluding Remarks

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500680

7 January 2021

based on heuristic

inferred from DOI database lookup

Tamsulosin 0.4 mg once daily: effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500680

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.PCAN.4500680

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44685341&oldid=2032180693"